These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 20019814)

  • 21. TLR-4 engagement of dendritic cells confers a BST-2/tetherin-mediated restriction of HIV-1 infection to CD4+ T cells across the virological synapse.
    Blanchet FP; Stalder R; Czubala M; Lehmann M; Rio L; Mangeat B; Piguet V
    Retrovirology; 2013 Jan; 10():6. PubMed ID: 23311681
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tetherin inhibits HIV-1 release by directly tethering virions to cells.
    Perez-Caballero D; Zang T; Ebrahimi A; McNatt MW; Gregory DA; Johnson MC; Bieniasz PD
    Cell; 2009 Oct; 139(3):499-511. PubMed ID: 19879838
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tetherin/BST-2: Restriction Factor or Immunomodulator?
    Li SX; Barrett BS; Guo K; Santiago ML
    Curr HIV Res; 2016; 14(3):235-46. PubMed ID: 26957198
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Quantitative multicolor super-resolution microscopy reveals tetherin HIV-1 interaction.
    Lehmann M; Rocha S; Mangeat B; Blanchet F; Uji-I H; Hofkens J; Piguet V
    PLoS Pathog; 2011 Dec; 7(12):e1002456. PubMed ID: 22194693
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tetherin restricts productive HIV-1 cell-to-cell transmission.
    Casartelli N; Sourisseau M; Feldmann J; Guivel-Benhassine F; Mallet A; Marcelin AG; Guatelli J; Schwartz O
    PLoS Pathog; 2010 Jun; 6(6):e1000955. PubMed ID: 20585562
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The formation of cysteine-linked dimers of BST-2/tetherin is important for inhibition of HIV-1 virus release but not for sensitivity to Vpu.
    Andrew AJ; Miyagi E; Kao S; Strebel K
    Retrovirology; 2009 Sep; 6():80. PubMed ID: 19737401
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Filamin A Is Involved in HIV-1 Vpu-mediated Evasion of Host Restriction by Modulating Tetherin Expression.
    Dotson D; Woodruff EA; Villalta F; Dong X
    J Biol Chem; 2016 Feb; 291(8):4236-46. PubMed ID: 26742839
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The C-Terminal End of HIV-1 Vpu Has a Clade-Specific Determinant That Antagonizes BST-2 and Facilitates Virion Release.
    Sharma S; Jafari M; Bangar A; William K; Guatelli J; Lewinski MK
    J Virol; 2019 Jun; 93(11):. PubMed ID: 30867310
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tetherin inhibits retrovirus release and is antagonized by HIV-1 Vpu.
    Neil SJ; Zang T; Bieniasz PD
    Nature; 2008 Jan; 451(7177):425-30. PubMed ID: 18200009
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characterization of E3 ligases involved in lysosomal sorting of the HIV-1 restriction factor BST2.
    Roy N; Pacini G; Berlioz-Torrent C; Janvier K
    J Cell Sci; 2017 May; 130(9):1596-1611. PubMed ID: 28320822
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Contribution of the Cytoplasmic Determinants of Vpu to the Expansion of Virus-Containing Compartments in HIV-1-Infected Macrophages.
    Leymarie O; Lepont L; Versapuech M; Judith D; Abelanet S; Janvier K; Berlioz-Torrent C
    J Virol; 2019 Jun; 93(11):. PubMed ID: 30867316
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Innate sensing of HIV-1 assembly by Tetherin induces NFκB-dependent proinflammatory responses.
    Galão RP; Le Tortorec A; Pickering S; Kueck T; Neil SJ
    Cell Host Microbe; 2012 Nov; 12(5):633-44. PubMed ID: 23159053
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tetherin/BST-2 is essential for the formation of the intracellular virus-containing compartment in HIV-infected macrophages.
    Chu H; Wang JJ; Qi M; Yoon JJ; Chen X; Wen X; Hammonds J; Ding L; Spearman P
    Cell Host Microbe; 2012 Sep; 12(3):360-72. PubMed ID: 22980332
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Influenza virus partially counteracts restriction imposed by tetherin/BST-2.
    Mangeat B; Cavagliotti L; Lehmann M; Gers-Huber G; Kaur I; Thomas Y; Kaiser L; Piguet V
    J Biol Chem; 2012 Jun; 287(26):22015-29. PubMed ID: 22493439
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antiviral Activity of Feline BCA2 Is Mainly Dependent on Its Interference With Proviral Transcription Rather Than Degradation of FIV Gag.
    Qu M; Wang W; Li W; Cao J; Zhang X; Wang C; Wu J; Yu B; Zhang H; Wu H; Kong W; Yu X
    Front Microbiol; 2020; 11():1230. PubMed ID: 32595622
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Species-specific activity of HIV-1 Vpu and positive selection of tetherin transmembrane domain variants.
    McNatt MW; Zang T; Hatziioannou T; Bartlett M; Fofana IB; Johnson WE; Neil SJ; Bieniasz PD
    PLoS Pathog; 2009 Feb; 5(2):e1000300. PubMed ID: 19214216
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tetherin is as tetherin does.
    Hammonds J; Spearman P
    Cell; 2009 Oct; 139(3):456-7. PubMed ID: 19879831
    [TBL] [Abstract][Full Text] [Related]  

  • 38. HIV-1 Vpu and HIV-2 Env counteract BST-2/tetherin by sequestration in a perinuclear compartment.
    Hauser H; Lopez LA; Yang SJ; Oldenburg JE; Exline CM; Guatelli JC; Cannon PM
    Retrovirology; 2010 Jun; 7():51. PubMed ID: 20529266
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Nef Protein of the Macrophage Tropic HIV-1 Strain AD8 Counteracts Human BST-2/Tetherin.
    Giese S; Lawrence SP; Mazzon M; Nijmeijer BM; Marsh M
    Viruses; 2020 Apr; 12(4):. PubMed ID: 32325729
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Suppression of Tetherin-restricting activity upon human immunodeficiency virus type 1 particle release correlates with localization of Vpu in the trans-Golgi network.
    Dubé M; Roy BB; Guiot-Guillain P; Mercier J; Binette J; Leung G; Cohen EA
    J Virol; 2009 May; 83(9):4574-90. PubMed ID: 19244337
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.